Trial · NCT02172573
Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
NCT02172573, Phase 3, Completed, Boehringer Ingelheim
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease. Trials, record NCT02172573. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02172573
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
- NCT number
- NCT02172573
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 315 participants, actual
- Lead sponsor
- Boehringer Ingelheim
- Conditions
- Parkinson Disease
- Interventions
- Pramipexole, Bromocriptine, Placebo pramipexole, Placebo bromocriptine
- First posted
- 2014-06-24
- Last updated
- 2014-06-24
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in total score of the Unified Parkinson's Disease Rating Scale (UPDRS) Part II (Activities of Daily Living) | Baseline and week 12 | |
| Primary | Change from baseline in total score of UPDRS Part III (Motor Examination) | Baseline and week 12 | |
| Secondary | Changes from baseline in sores of individual items on UPDRS Part II | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Changes from baseline in scores of individual items on UPDRS Part III | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in area under the curve (AUC) in the UPDRS Part II score | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in area under the curve (AUC) in the UPDRS Part III score | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I (mentation, behaviour and mood) | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part IV (complications of therapy) | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I-III | Baseline and weeks 2, 4, 6, 8, 10, 12 | |
| Secondary | Change from baseline in total score of UPDRS Part I-IV | Baseline and weeks 2, 4, 6, 8, 10, 12 |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02172573
GET https://conductscience.org/api/trials/v1/NCT02172573/registered